Understanding how older age drives decision-making and outcome in Immune Thrombocytopenia. A single centre study on 465 adult patients

Splenectomy for immune thrombocytopenia: down but not out

(2018) Shruti Chaturvedi et al.   BLOOD

Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long-term response

(2017) Miriam Marangon et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Clinical Outcome and Predictive Factors in the Response to Splenectomy in Elderly Patients with Primary Immune Thrombocytopenia: A Multicenter Retrospective Study

(2016) Young Hoon Park et al.   ACTA HAEMATOLOGICA

Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years

(2016) Francesca Palandri et al.   AMERICAN JOURNAL OF HEMATOLOGY

How we manage immune thrombocytopenia in the elderly

(2016) Matthieu Mahévas et al.   BRITISH JOURNAL OF HAEMATOLOGY

Is ITP a thrombophilic disorder?

(2015) Francesco Rodeghiero   AMERICAN JOURNAL OF HEMATOLOGY

Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged ≥65 years with immune thrombocytopenia

(2015) Marc Michel et al.   ANNALS OF HEMATOLOGY

A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP

(2015) H. Zhou et al.   BLOOD

Risk of thromboembolism with thrombopoietin receptor agonists in adult patients with thrombocytopenia: Systematic review and meta-analysis of randomized controlled trials

(2015) Ferrán Catalá-López et al.   MEDICINA CLINICA

Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients

(2014) M. Khellaf et al.   BLOOD

Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France

(2014) G. Moulis et al.   BLOOD

Safety and efficacy of splenectomy in over 65-yrs-old patients with immune thrombocytopenia

(2013) Jose R. Gonzalez-Porras et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years

(2012) N. Vianelli et al.   HAEMATOLOGICA

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia

(2011) C. Neunert et al.   BLOOD

Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group

(2011) T. Kuhne et al.   HAEMATOLOGICA

Toxicities of the Thrombopoietic Growth Factors

(2010) Adam Cuker   SEMINARS IN HEMATOLOGY

International consensus report on the investigation and management of primary immune thrombocytopenia

(2009) D. Provan et al.   BLOOD

Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production

(2009) Diane Nugent et al.   BRITISH JOURNAL OF HAEMATOLOGY

Immune thrombocytopenic purpura: epidemiology and implications for patients

(2009) Marc Michel   EUROPEAN JOURNAL OF HAEMATOLOGY

CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting

(2008) Teresa C. Horan et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study

(2008) B. Godeau et al.   BLOOD

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

(2008) F. Rodeghiero et al.   BLOOD

Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results

(2008) Marta Medeot et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

(2008) David J Kuter et al.   LANCET

Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura

(2008) Suley Mara Chaddad Vancine-Califani et al.   PLATELETS